Sumitovant Biopharma
Show contact
Christine Ocampo is responsible for the accounting, tax and audit functions for Sumitovant Biopharma. She previously served as Chief Accounting Officer of Urovant Sciences, Inc. since Urovant’s initial inception in 2017.
Myrtle Potter
CEO
Christine Ocampo
Chief Accounting Officer
Bill McMahon
Chief Algorithmic Analytics Officer
Sam Azoulay
CMO, Head of Research & Development
Mi Yong Cho
Chief People Officer
+ 7 more
Yu Ling Sharpe
Senior Manager, Accounting
Current role
View in org chart